Clinical Trial Update: A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of Trebananib (AMG 386) in adult Japanese participants with advanced solid tumors; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Trebananib (AMG 386) (trebananib)

Snippet

Sponsor: Takeda | Conditions: Neoplasms, Advanced Solid | Phase 1 | Status: COMPLETED | Results posted: 2015-09-22